Neuroscientist with expertise in cellular and molecular mechanisms with special emphasis on neurological and neuropsychiatric disorders. Extensive knowledge of brain circuits that play a central role in epilepsy and autism. Proven track record of delivering scientific results through rigorous analysis of complex data, writing and publishing scientific manuscripts in top peer-reviewed journals such as Nature, Molecular Cell, and J Neuroscience, and presenting research at national and international scientific conferences. Extensive experience in evaluating a broad range of disruptive gene therapies and innovative technologies in life sciences as an advisor for the Endless Frontier Labs program - NYU flagship startup mentorship program, and effective leader & manager of interdisciplinary teams with the ability to act as liaison across various departments and institutes. Worked as biotech consultant to keep up with advances in R&D Clinical Development and commercial potential, and strong business acumen and financial forecasting skills acquired while working at Oppenheimer & Co. equity research team as a consultant on investment strategy in clinical stage companies focusing on novel therapies for neurological and neurodegenerative disorders. Driven by a passion to advance cost-effective powerful therapeutics by leveraging innovative technology. Strong communication skills: experienced in mentoring and lecturing to diverse scientific and medical audiences